A New Scalp Formulation of Calcipotriene plus Betamethasone Compared with Its Active Ingredients and the Vehicle in the Treatment of Scalp Psoriasis: A Randomized, Double-Blind, Controlled Trial
AuthID
P-003-WMZ
P-003-WMZ